1a4g

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
The first paper in this series (see previous article) described, structure-activity studies of carboxamide analogues of zanamivir binding, to influenza virus sialidase types A and B and showed that inhibitory, activity of these compounds was much greater against influenza A enzyme., To understand the large differences in affinities, a number of, protein-ligand complexes have been investigated using crystallography and, molecular dynamics. The crystallographic studies show that the binding of, ligands containing tertiary amide groups is accompanied by the formation, of an intramolecular planar salt bridge between two amino acid residues in, the active site of the enzyme. It is proposed that the unexpected strong, binding of these inhibitors is a result of the burial of hydrophobic, surface area and salt-bridge formation in an environment of low, dielectric. In sialidase from type A virus, binding of the carboxamide, moeity and salt-bridge formation have only a minor effect on the positions, of the surrounding residues, whereas in type B enzyme, significant, distortion of the protein is observed. The results suggest that the, decreased affinity in enzyme from influenza B is directly correlated with, the small changes that occur in the amino acid residue interactions, accompanying ligand binding. Molecular dynamics calculations have shown, that the tendency for salt-bridge formation is greater in influenza A, sialidase than influenza B sialidase and that this tendency is a useful, descriptor for the prediction of inhibitor potency.
+
The first paper in this series (see previous article) described structure-activity studies of carboxamide analogues of zanamivir binding to influenza virus sialidase types A and B and showed that inhibitory activity of these compounds was much greater against influenza A enzyme. To understand the large differences in affinities, a number of protein-ligand complexes have been investigated using crystallography and molecular dynamics. The crystallographic studies show that the binding of ligands containing tertiary amide groups is accompanied by the formation of an intramolecular planar salt bridge between two amino acid residues in the active site of the enzyme. It is proposed that the unexpected strong binding of these inhibitors is a result of the burial of hydrophobic surface area and salt-bridge formation in an environment of low dielectric. In sialidase from type A virus, binding of the carboxamide moeity and salt-bridge formation have only a minor effect on the positions of the surrounding residues, whereas in type B enzyme, significant distortion of the protein is observed. The results suggest that the decreased affinity in enzyme from influenza B is directly correlated with the small changes that occur in the amino acid residue interactions accompanying ligand binding. Molecular dynamics calculations have shown that the tendency for salt-bridge formation is greater in influenza A sialidase than influenza B sialidase and that this tendency is a useful descriptor for the prediction of inhibitor potency.
==About this Structure==
==About this Structure==
Line 17: Line 17:
[[Category: Singh, O.]]
[[Category: Singh, O.]]
[[Category: Skarzynski, T.]]
[[Category: Skarzynski, T.]]
-
[[Category: Wonacott, A.J.]]
+
[[Category: Wonacott, A J.]]
[[Category: CA]]
[[Category: CA]]
[[Category: NAG]]
[[Category: NAG]]
Line 25: Line 25:
[[Category: hydrolase]]
[[Category: hydrolase]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 09:28:59 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 11:40:48 2008''

Revision as of 09:40, 21 February 2008


1a4g, resolution 2.2Å

Drag the structure with the mouse to rotate

INFLUENZA VIRUS B/BEIJING/1/87 NEURAMINIDASE COMPLEXED WITH ZANAMIVIR

Overview

The first paper in this series (see previous article) described structure-activity studies of carboxamide analogues of zanamivir binding to influenza virus sialidase types A and B and showed that inhibitory activity of these compounds was much greater against influenza A enzyme. To understand the large differences in affinities, a number of protein-ligand complexes have been investigated using crystallography and molecular dynamics. The crystallographic studies show that the binding of ligands containing tertiary amide groups is accompanied by the formation of an intramolecular planar salt bridge between two amino acid residues in the active site of the enzyme. It is proposed that the unexpected strong binding of these inhibitors is a result of the burial of hydrophobic surface area and salt-bridge formation in an environment of low dielectric. In sialidase from type A virus, binding of the carboxamide moeity and salt-bridge formation have only a minor effect on the positions of the surrounding residues, whereas in type B enzyme, significant distortion of the protein is observed. The results suggest that the decreased affinity in enzyme from influenza B is directly correlated with the small changes that occur in the amino acid residue interactions accompanying ligand binding. Molecular dynamics calculations have shown that the tendency for salt-bridge formation is greater in influenza A sialidase than influenza B sialidase and that this tendency is a useful descriptor for the prediction of inhibitor potency.

About this Structure

1A4G is a Single protein structure of sequence from Influenza b virus with , and as ligands. Active as Exo-alpha-sialidase, with EC number 3.2.1.18 Known structural/functional Sites: , , , , and . Full crystallographic information is available from OCA.

Reference

Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B., Taylor NR, Cleasby A, Singh O, Skarzynski T, Wonacott AJ, Smith PW, Sollis SL, Howes PD, Cherry PC, Bethell R, Colman P, Varghese J, J Med Chem. 1998 Mar 12;41(6):798-807. PMID:9526556

Page seeded by OCA on Thu Feb 21 11:40:48 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools